Origins, Epidemiology and the COVID-19 Vaccine

This chapter provides a comprehensive discussion of the origins, epidemiology, and timeline of the COVID-19 pandemic, focusing particularly on developing and deploying COVID-19 vaccines. Beginning with an overview of the virus’s emergence and spread, the chapter discusses the authorisation of vaccines amid imperfect information, leading to public mistrust in governments and pharmaceutical companies. Subsequently, the chapter delves into retrospective revelations concerning the shortcomings of pharmaceutical companies in ensuring the efficacy of the COVID-19 vaccine. This factor significantly contributed to vaccine hesitancy among the public. We emphasise the obligation of pharmaceutical companies to rebuild public trust actively. They must convincingly demonstrate their commitment to rigorous safety protocols during vaccine trials, a transparent approach to potential side effects, and a resolute avoidance of any involvement in controversial gain-of-function research. Additionally, alternative pharmaceutical interventions to alleviate COVID-19 symptoms are discussed, advocating for improved access through policy intervention. The chapter also outlines the various non-pharmaceutical interventions governments employed to mitigate the spread of COVID-19 and highlights the impact of lockdown regulations. Lastly, it delves into the complexities of pharmaceutical interventions, examining the rapid development and approval of vaccines, transparency issues, and public trust erosion. The chapter concludes with a call for equitable access to antiviral medications to combat future outbreaks effectively.